EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Spurious HbA1c results in patients with diabetes treated with dapsone

Khaled Aljenaee, Osamah Hakami, Colin Davenport, Gemma Farrell, Tommy Kyaw Tun, Agnieszka Pazderska, Niamh Phelan, Marie-Louise Healy, Seamus Sreenan, John H McDermott

Endocrinology, Diabetes & Metabolism Case Reports · 27.09.2019 · 2019

DOI: 10.1530/edm-19-0027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, erschienen am 27.09.2019. Verfasst von Khaled Aljenaee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, St James Hospital, Dublin, Ireland. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measurement of glycated haemoglobin (HbA1c) has been utilised in assessing long-term control of blood glucose in patients with diabetes, as well as diagnosing diabetes and identifying patients at increased risk of developing diabetes in the future. HbA1c reflects the level of blood glucose to which the erythrocyte has been exposed during its lifespan, and there are a number of clinical situations affecting the erythrocyte life span in which HbA1c values may be spuriously high or low and therefore not reflective of the true level of glucose control. In the present case series, we describe the particulars of three patients with diabetes who had spuriously low HbA1c levels as a result of dapsone usage. Furthermore, we discuss the limitations of HbA1c testing and the mechanisms by which it may be affected by dapsone in particular. Learning points: Various conditions and medications can result in falsely low HbA1c. Dapsone can lead to falsely low HbA1c by inducing haemolysis and by forming methaemoglobin. Capillary glucose measurement, urine glucose measurements and fructosamine levels should be used as alternatives to HbA1c for monitoring glycaemic control if it was falsely low or high.

Schlagwörter

Stichwörter der Autor:innen

2019AdultAnaemiaAntibioticsBilirubinCoeliac diseaseCoeliac disease*DapagliflozinDapsone*Dermatitis herpetiformis*DiabetesDiabetes mellitus type 1Diabetes mellitus type 2FemaleFructosamine*

Autor:innen und Institutionen

  • Department of Endocrinology, St James Hospital, Dublin, Ireland.
  • Department of Endocrinology, Royal College of Surgeons in Ireland, Connolly Hospital Blanchardstown, Dublin, Ireland.
  • Department of Endocrinology, St Columcille's Hospital, Dublin, Ireland.
  • Department of Clinical Biochemistry, Connolly Hospital, Blanchardstown, Dublin, Ireland.

Zitieren

APA

Aljenaee, K., Hakami, O., Davenport, C., Farrell, G., Tun, T. K., Pazderska, A., Phelan, N., Healy, M. L., Sreenan, S., & McDermott, J. H. (2019). Spurious HbA1c results in patients with diabetes treated with dapsone. Endocrinology, Diabetes & Metabolism Case Reports, 2019. https://doi.org/10.1530/edm-19-0027

Vancouver

Aljenaee K, Hakami O, Davenport C, Farrell G, Tun TK, Pazderska A, et al. Spurious HbA1c results in patients with diabetes treated with dapsone. Endocrinology, Diabetes & Metabolism Case Reports. 2019;2019. doi:10.1530/edm-19-0027

BibTeX
@article{Aljenaee2019,
  author = {Aljenaee, Khaled and Hakami, Osamah and Davenport, Colin and Farrell, Gemma and Tun, Tommy Kyaw and Pazderska, Agnieszka and Phelan, Niamh and Healy, Marie-Louise and Sreenan, Seamus and McDermott, John H},
  title = {Spurious HbA1c results in patients with diabetes treated with dapsone},
  journal = {Endocrinology, Diabetes & Metabolism Case Reports},
  year = {2019},
  volume = {2019},
  doi = {10.1530/edm-19-0027}
}
Kostenlos starten →